Healthcare

Healthcare

Healthcare  Contact Us

Healthcare

There are many challenges facing healthcare, from aging populations, rapidly growing demand for health products and services, severe budget pressures and government reform to global health threats that defy conventional approaches. And each challenge requires the most imaginative of minds – people willing to ask big questions, take risks and tackle complex problems in new ways. At FleishmanHillard, we believe...

There are many challenges facing healthcare, from aging populations, rapidly growing demand for health products and services, severe budget pressures and government reform to global health threats that defy conventional approaches. And each challenge requires the most imaginative of minds – people willing to ask big questions, take risks and tackle complex problems in new ways. At FleishmanHillard, we believe there's an answer to every question that can be posed – we just have to be curious, persistent, collaborative and creative enough to find it. So regardless of the task – building brand loyalty, educating the public or defending a marketplace in the face of intense competition – our team provides the curiosity, experience and confidence to push the boundaries of healthcare communications.

What We Do

Reputation Management

Our teams provide a wide spectrum of reputation management consulting services, from support for leadership changes and mergers and acquisitions to employee communications, issues preparedness and crisis response. Equipped with proprietary tools such as our Authenticity Gap methodology, we help organizations across the healthcare sector identify and take positive steps toward managing the gaps between their brand and reputation.

Product Launch and Marketing

Each market and therapeutic category provides its own challenges, opportunities and circle of stakeholders. From clinical trial recruitment to end-of-lifecycle strategies, FleishmanHillard provides insights into the introduction and marketing of new and mature products. With a deep understanding of the regulatory environments and market complexities in which they work, our counselors have helped create powerful campaigns to launch products at a global, regional and national level – shaping a positive environment for product uptake and generating ongoing demand.

Clinical Trial Recruitment

FleishmanHillard provides specialized patient recruitment consulting for investigational pharmaceutical, biotechnology and medical device products. Working collaboratively with contract research organizations and our clients, we engage target populations through credible third-party sources – online and off – helping study sites raise awareness, educate and generate referrals.

Public Affairs and Government Relations

FleishmanHillard provides an in-depth understanding of local, regional and global healthcare issues, advocacy, alliance development, stakeholder engagement and government affairs. We help healthcare companies, trade associations and nongovernmental organizations navigate regulation, mobilize opinion leaders, and influence legislation and health policy. Our healthcare-focused public affairs experts around the world have extensive experience counseling organizations on the wide range of product, corporate and marketplace issues.

Digital and Social Outreach

FleishmanHillard’s digital and social experts worldwide help organizations apply new technologies, tools and channels to shape integrated communications programs that create a measurable impact. We work with clients to optimize the power of social media, including implementing policies for employees, launching branded promotional and unbranded educational campaigns, working with HR to enhance recruitment and retention, and coaching executives in the medium.

Verticals

Animal healthcare
Biotechnology
Health NGOs
Healthcare technology providers
Managed care and insurance providers
Medical equipment and device makers
Medical facilities and providers
Pharmaceuticals
Wholesalers

Who We Are


Healthcare
  • Why Media Coverage of Medical Research is Making John Oliver Mad, and What PR Pros Could Do to Help

    Adam Silverstein

    May 10, 2016

    Adam Silverstein You’ve seen the headlines. They appeared on your Facebook feed, your Twitter handle and your local news. You probably overheard someone mention one on your way to work. Maybe you’ve even seen these: “Swaddling May Be Linked to SIDS, New Research Analysis Suggests” “Eating Moderate Amounts of Chocolate Could Benefit Mom and Baby” “Drinking a...

  • Donald Trump’s 7-Point Healthcare Plan

    Richard Sorian

    March 4, 2016

    Richard Sorian Now that his road to the Republican nomination for President seems to be getting shorter, Donald Trump has released a seven-point plan for healthcare reform. But, like much in this campaign to date, it is short on details and new ideas. In fact, what’s remarkable about the plan is what is NOT in it. Trump’s...

  • Is It Enough to Mean Well? The Importance of Empathy

    Heather Pierce

    March 3, 2016

    Heather Pierce A few weeks ago, I was helping to lead a client message training session for an amazing group of female philanthropists. These women are leading incredible global health initiatives, from addressing gender-based violence in Honduras and Trinidad to transforming sanitation in Vietnam and detecting and treating cervical cancer in India. As we were discussing their...

  • Considerations for a New FDA Commissioner

    Mark Senak

    February 26, 2016

    Mark Senak The Senate, in an 89-4 vote, confirmed Dr. Robert Califf as the new Commissioner for the Food and Drug Administration, which oversees the regulation of about one-fourth of the U.S. economy. With several “Holds” put on the nomination by more than a few members, including Senators Manchin, Markey, Murkowski and Sanders the question was whether...

  • 10 Things We Know About the U.S. Presidential Candidates and Healthcare

    Richard Sorian

    February 24, 2016

    Richard Sorian The 2016 presidential election keeps rolling along with fewer candidates and many more primaries and caucuses. While issues like immigration and economic justice have dominated the debates and media coverage so far, healthcare continues to pop up fairly frequently. For example: Four candidates – Hillary Clinton, Bernie Sanders, Marco Rubio and Donald Trump – have...

  • Why Do Democrats Keep Fighting Over Healthcare?

    Richard Sorian

    February 2, 2016

    Richard Sorian “In short [my opponent] offers a flawed trillion-dollar plan that will cost the American people even more in the long run." "[My opponent] abandoned that fundamental Democratic principle of basic health care for all Americans.” You may think these quotes were quite likely uttered just last week as the Democrats running for President made their...

  • What a Difference a Year Makes: Three Observations from the JPM Healthcare Conference

    Adam Silverstein

    January 25, 2016

    Adam Silverstein Hotel room rates in San Francisco have resumed being just expensive, not uber-expensive. Union Square is crowded, not overflowing. Sports talk in bars and restaurants is more likely to be about real football – the Super Bowl, Monday morning quarterbacks, watching from the sidelines, dropping the ball – than borrowed football metaphors to describe business...

  • Keeping Score: The State of Healthcare in Obamaland

    Richard Sorian

    January 13, 2016

    Richard Sorian One of Washington’s favorite parlor games is to dissect major speeches by the President to see what signals he might be sending to the American people. How long was the speech? What topics got the most attention? The least attention? Did he mention my pet topic? The annual State of the Union (SOTU) address to...

  • Five Things to Watch for at the J.P. Morgan Healthcare Conference

    Adam Silverstein

    January 12, 2016

    Adam Silverstein San Francisco’s population is swelling, but the rising wave of people, much like the bay at high tide, will ebb. The flow of people into the city, specifically Union Square, is an effect of the 34th Annual J.P. Morgan (JPM) Healthcare Conference (JPM is a FleishmanHillard client), happening this week in San Francisco as it...

  • Kentucky: Microcosm for National Healthcare Debate

    Erin Seidler

    November 9, 2015

    Erin Seidler Kentucky has always been the best state in America for bluegrass, horse racing and bourbon. But Kentucky is also gaining national recognition in an unexpected area: becoming a microcosm for the national debate over Obamacare. On Tuesday night, voters elected Republican Matt Bevin to succeed Democrat Steve Beshear as the state’s next governor. Beshear created...

  • The Coming Storm

    Richard Sorian

    November 6, 2015

    Richard Sorian A sizzling summer of media coverage of rising drug prices – fueled by the made-for-TV news about Turing Pharmaceuticals’ 5000% price hike for Daraprim, a drug approved by the FDA in 1953 to treat malaria and toxoplasmosis – is turning into an autumn of activity on Capitol Hill. As a result, the long-brewing debate over...

  • What Really Scares Me This Halloween

    Fran Carpentier

    October 30, 2015

    Fran Carpentier Halloween’s calling, and my heart’s in the right place—for a person living with Type 1 diabetes, that is. You see, despite my compliance to carb-counting and almost hourly blood tests, I’ve deep-rooted affection for this holiday of camp and kitsch and candy. But just like Cinderella (my all-time favorite princess-in-waiting if not Halloween costume), I...

  • A Healthy Debate – What the Candidates Are Saying

    Richard Sorian

    October 15, 2015

    Richard Sorian U.S. presidential candidates from both parties have now held at least one nationally televised debate and healthcare played a prominent role in both. We ran a quick analysis of the most current Republican and Democratic debate transcripts, and some of what was said really surprised us. Think you know what’s what? Try this fast quiz:...

  • Can Technology Bridge the Gap Between Knowing and Doing?

    Heather Pierce

    October 14, 2015

    Heather Pierce Chronic disease prevention isn’t sexy. Its core tenets induce eye rolls with their basic simplicity: “Eat better. Exercise more.” Ugh, how boring. Isn’t there some pill I can take to stave off a heart attack or cancer? A one-time shot to make me diabetes-proof? Healthcare providers and public health professionals have long struggled with how...

  • The Five Healthcare Issues That Will Dominate the 2016 Election

    Erin Seidler

    September 28, 2015

    Erin Seidler Is Donald Trump’s hair real or fake? Is Hillary Clinton’s server clean or not? We’re as fascinated by these questions as anyone else and will debate these questions and more in our next blog post. As we trudge through September, October and then another 12 months until the election, we’ve begrudgingly accepted that the political...

  • Speaking of Health – How the 21st Century Cures Act Impacts Healthcare Communications

    Mark Senak

    July 10, 2015

    Mark Senak The pace of change in healthcare is breathtaking. There are new ways to treat, new ways to research, new ways to pay for care, new ways to access care and new ways to communicate about it. Yet, in too many ways, the way we, as a nation, regulate remains a 20th century model plagued by...

  • SCOTUS Saves POTUS: How the ACA Verdict Affects Healthcare

    Richard Sorian

    June 25, 2015

    Richard Sorian Today’s 6-3 decision by the Supreme Court of the United States (SCOTUS) hands a huge victory to Barack Obama, the President of the United States (POTUS), locking in place one of the President’s signature public policy initiatives of his two terms in the White House. While the political debate and legal challenges to the Affordable...

  • Social Media at ASCO: Weekend in Review

    Adam Silverstein

    June 1, 2015

    Adam Silverstein Day 4 at the American Society of Clinical Oncology (ASCO) conference in Chicago brings with it some weary attendees and followers. Hundreds of abstracts have been presented on a range of cancers and generated some large conversation volumes, both in McCormick Place and online. On Friday, we previewed three topics and trends we’re watching at the meeting....

  • Sweet Home Chicago: What We’ll Be Watching at ASCO

    Adam Silverstein

    May 29, 2015

    Adam Silverstein Chicago, get ready. You’re about to have a lot more doctors, business executives and journalists. Thousands of them are gathering in the Windy City for the annual American Society of Clinical Oncology (ASCO), one of the largest oncology meetings in the world. While the surge will be temporary, the research and insights shared by oncologists...

  • Are We Too Optimistic About Progress in Cancer?

    Adam Silverstein

    April 29, 2015

    Adam Silverstein A giddy smile has taken hold of the faces of many oncologists and cancer patients. They have good reason to grin, for three reasons: We could be on the way toward doing away with the cancer biopsy. Researchers reported that a “liquid biopsy” blood test that’s possible due to advanced genome sequencing can find tiny pieces of cancer DNA in...

  • The FH 2015 Social Health Survey: A Second Opinion From Dr. Digital

    Alyssa Marderstein

    April 20, 2015

    Alyssa Marderstein Melissa Solomon and Adam Silverstein contributed to this article. Survey finds over 50% of patients consult with Dr. Google or Facebook before or after a doctor’s visit Our Social Health survey of more than 500 people reveals some important patient behaviors. First, patients form an opinion about a treatment option before they step foot in...

  • The FleishmanHillard 2015 Social Health Survey

    Ephraim Cohen

    April 7, 2015

    Ephraim Cohen How people care for themselves and others using social and mobile media Which networks people use and how they use them differs greatly depending on age range as well as whether the person is looking for information about their own health or finding information as a caregiver to someone else. The charts below show the...

  • The Affordable Care Act Turns 5

    Erin Seidler

    March 27, 2015

    Erin Seidler This week marks the 5th anniversary of the passage of the Affordable Care Act. While the law appears to be making progress toward achieving its goals, it remains as divisive as ever and continues to face attempts to dismantle the law. Just last month, emboldened by the new Republican majority in the U.S. Senate, the...

  • The New, New Healthcare Law

    Richard Sorian

    March 27, 2015

    Richard Sorian Like the homeowner who winds up tripling his remodeling budget by telling the contractor “While you’re at it, can you ..." Congress is wrapping up what might be the most significant healthcare bill since the Affordable Care Act of 2010. What started out as a bill to fix a broken Medicare payment system for doctors...

  • Good News for Doctors and Children!

    Richard Sorian

    March 19, 2015

    Richard Sorian Congress is poised to do something remarkable. Republicans and Democrats in the House and Senate are ready to enact legislation putting an end to an 18-year odyssey that alienated millions of physicians and created a continual environment of uncertainty for both practitioners and a vulnerable patient population. At the same time, they plan to extend...

  • Does the Affordable Care Act Have Nine Lives?

    Richard Sorian

    March 5, 2015

    Richard Sorian Today’s oral arguments before the U.S. Supreme Court are just the latest challenge to the Affordable Care Act (ACA), the sweeping healthcare reform law enacted in 2010 also known as “Obamacare”. And it is not likely it will be the last. This isn’t the first time the pundits declared the ACA DOA: In 2009, the...

  • Changes Afoot for Vaccine Production in Russia

    Marina Yarovikova

    February 3, 2015

    Marina Yarovikova The Russian Ministry of Health plans to bring all Russian vaccine producers into a single national immune-biological cluster in 2015. In Russia, the market for the vaccines included in the National Immunization Schedule is quite a special segment of the pharmaceutical market. The main buyer of prophylactic vaccines is the State, which is also the...

  • It’s the Most Wonderful Time of Year

    Adam Silverstein

    January 16, 2015

    Adam Silverstein It’s the most wonderful time of year. For healthcare, that is. This week in San Francisco, over 300 healthcare companies, both public and private, presented vision, business objectives, challenges and opportunities for 2015 at arguably the year’s largest meeting, the 33rd Annual J.P. Morgan (client) Healthcare Conference. Investors, media, healthcare professionals, even patient advocates swarmed...

  • Taking the Pulse: Obamacare Round Two

    Richard Sorian

    November 11, 2014

    Richard Sorian Hard to believe it’s time for the second year of full implementation of the Affordable Care Act —aka Obamacare. On November 15, the health insurance marketplaces reopen for business for Americans to shop for private health insurance. Proponents are hoping this year will look nothing like last year’s debacle. The Obama Administration, worried about setting...

  • Taking the Pulse: What Will the New Congress Prescribe on Healthcare Policy?

    Richard Sorian

    November 6, 2014

    Richard Sorian Now that the 2014 elections are more or less over (ah, runoffs…) it’s time to consider their impact. Republicans made strong gains in both houses of Congress, cementing their already strong majority in the House and retaking control of  the Senate in resounding fashion.  Republicans also made gains at the state level and held off...

Most Recent

  • Why Media Coverage of Medical Research is Making John Oliver Mad, and What PR Pros Could Do to Help

  • Donald Trump’s 7-Point Healthcare Plan

  • Is It Enough to Mean Well? The Importance of Empathy

  • Considerations for a New FDA Commissioner

  • 10 Things We Know About the U.S. Presidential Candidates and Healthcare

By Author

By Date